CytoDyn Inc. (CYDY) · 10+ Years of Financial statements

Income Statement	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	21
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	21
Gross Profit	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-21
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-21
- Operating Expenses	2	4	4	7	8	8	20	21	27	46	56	75	95	72	41
+ Selling, General & Admin	1	3	3	7	7	4	4	7	7	7	12	20	34	44	17
+ Research & Development	- -	- -	- -	1	1	4	15	14	20	38	42	53	58	27	3
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	1	21
Operating Income (Loss)	-2	-4	-4	-7	-8	-8	-20	-21	-27	-46	-56	-75	-95	-72	-41
- Non-Operating (Income) Loss	- -	- -	- -	- -	2	4	5	5	-2	4	3	50	60	139	39
+ Interest Expense, Net	- -	- -	- -	- -	2	4	5	4	1	5	3	17	19	52	7
+ Interest Expense	- -	- -	- -	- -	2	4	5	4	1	5	3	17	19	52	7
- Interest Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	- -	- -	1	- -	-2	-1	- -	33	41	86	32
Pretax Income	-2	-3	-4	-7	-10	-12	-25	-26	-26	-50	-59	-124	-155	-211	-80
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-3	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-2	-4	-4	-7	-10	-12	-25	-26	-26	-50	-56	-124	-155	-211	-80
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-2	-4	-4	-7	-10	-12	-25	-26	-26	-50	-56	-124	-155	-211	-80
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-2	-4	-4	-7	-10	-12	-25	-26	-26	-50	-56	-124	-155	-211	-80
- Preferred Dividends	- -	6	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	1
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-2	-10	-4	-8	-10	-12	-25	-26	-26	-50	-56	-125	-156	-212	-81
Basic Weighted Avg Shares	14	19	21	25	30	47	58	95	138	175	272	421	588	677	837
Basic EPS, GAAP	-0.11	-0.51	-0.18	-0.31	-0.32	-0.27	-0.43	-0.27	-0.19	-0.29	-0.21	-0.3	-0.27	-0.31	-0.1
Basic EPS from Cont Ops	-0.11	-0.2	-0.18	-0.3	-0.32	-0.27	-0.43	-0.27	-0.19	-0.29	-0.21	-0.3	-0.26	-0.31	-0.1
Diluted Weighted Avg Shares	14	19	21	25	30	47	58	95	138	175	272	421	588	677	837
Diluted EPS, GAAP	-0.11	-0.51	-0.18	-0.31	-0.32	-0.27	-0.43	-0.27	-0.19	-0.29	-0.21	-0.3	-0.27	-0.31	-0.1
Diluted EPS from Cont Ops	-0.11	-0.2	-0.18	-0.3	-0.32	-0.27	-0.43	-0.27	-0.19	-0.29	-0.21	-0.3	-0.26	-0.31	-0.1
EBITDA	-2	-4	-4	-7	-8	-8	-19	-21	-27	-46	-55	-73	-93	-71	-40
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-26,741.73	- -
EBITA	-2	-4	-4	-7	-8	-8	-20	-21	-27	-46	-56	-75	-95	-72	-41
EBIT	-2	-4	-4	-7	-8	-8	-20	-21	-27	-46	-56	-75	-95	-72	-41
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	80.08	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-27,035.34	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-79,255.64	- -
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11,565	- -
Dividend per Share	- -	- -	- -	6.09	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	1	- -

Balance Sheet	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	- -	1	2	1	1	5	2	11	6	3	5	37	130	28	11
+ Cash, Cash Equivalents & STI	- -	1	- -	- -	1	5	1	10	2	1	3	14	34	4	3
+ Cash & Cash Equivalents	- -	1	- -	- -	1	5	1	10	2	1	3	14	34	4	3
+ ST Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19	93	18	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19	28	16	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	65	2	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	- -	2	1	- -	1	1	2	4	2	3	3	2	6	8
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -	3	3	3	2	2	2	16	14	2	1	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -
+ Property, Plant & Equip	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -	3	3	3	2	2	2	15	13	2	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -	3	3	3	2	2	2	15	13	2	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	3	3	3	2	2	2	15	13	2	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Assets	- -	1	2	1	4	8	5	14	8	5	21	51	132	29	11
+ Payables & Accruals	- -	- -	1	1	2	2	9	4	5	16	18	38	90	84	85
+ Accounts Payable	- -	- -	1	1	1	1	5	2	4	16	16	29	66	68	63
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	- -	1	1	4	1	1	- -	2	8	24	16	22
+ ST Debt	- -	- -	- -	- -	1	- -	2	- -	1	- -	8	7	63	36	34
+ ST Borrowings	- -	- -	- -	- -	1	- -	2	- -	1	- -	8	7	63	36	34
+ ST Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	6	4	1	- -	- -	- -	- -	1	1	- -	- -	3	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	6	4	1	- -	- -	- -	- -	1	1	- -	- -	3	- -
Total Current Liabilities	- -	- -	7	5	3	2	11	4	6	17	27	45	153	123	120
+ LT Debt	- -	- -	- -	- -	1	2	3	- -	- -	- -	- -	8	1	- -	1
+ LT Borrowings	- -	- -	- -	- -	1	2	3	- -	- -	- -	- -	8	- -	- -	1
+ LT Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -
+ Other LT Liabilities	- -	- -	- -	- -	- -	- -	2	- -	3	1	2	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -	- -	- -	- -	2	- -	3	1	2	- -	- -	- -	- -
Total Noncurrent Liabilities	1	- -	- -	- -	1	2	5	- -	3	1	3	8	1	- -	1
Total Liabilities	1	1	7	5	4	5	15	4	9	18	30	53	153	124	121
+ Preferred Equity and Hybrid Capital	- -	2	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	9	12	24	23	34	50	61	107	122	160	220	352	490	672	732
+ Common Stock	- -	- -	9	15	16	30	36	- -	- -	- -	- -	1	1	1	1
+ Additional Paid in Capital	9	12	15	8	18	20	25	107	122	160	220	352	490	671	731
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-10	-14	-15	-23	-34	-46	-72	-97	-123	-173	-229	-355	-511	-766	-842
+ Other Equity	- -	-2	-2	-2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-1	- -	-5	-4	- -	4	-11	10	-1	-13	-9	-2	-21	-94	-110
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	-1	- -	-5	-4	- -	4	-11	10	-1	-13	-9	-2	-21	-94	-110
Total Liabilities & Equity	- -	1	2	1	4	8	5	14	8	5	21	51	132	29	11
Shares Outstanding	16	20	22	29	31	56	64	123	149	217	329	519	626	720	919
Capital Leases - Total	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -
Net Debt	- -	-1	- -	- -	1	-3	3	-10	-1	-1	6	1	29	32	33
Net Debt to Equity	-12.2	-392.46	-3.06	5.07	-619.29	-64.95	-30.13	-94.48	64.99	9.36	-63.13	-36.01	-137.04	-33.91	-29.76
Tangible Common Equity Ratio	-284.97	-250.32	-329.57	-432.67	-453.95	12.61	-657.48	68.91	-49.21	-441.95	-451.77	-43	-17.38	-325.37	-969.72
Current Ratio	0.55	1.93	0.28	0.2	0.26	2.51	0.19	3.21	1	0.2	0.2	0.83	0.85	0.23	0.09
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	383,945.5	- -
Number of Employees	4	4	5	5	2	3	3	5	6	6	10	19	24	23	12

Cash Flow Statement	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-2	-4	-4	-7	-10	-12	-25	-26	-26	-50	-56	-124	-155	-211	-80
+ Depreciation & Amortization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	1	- -
+ Non-Cash Items	- -	2	1	3	5	5	6	7	- -	5	3	55	55	137	56
+ Stock-Based Compensation	1	2	1	3	4	1	1	2	1	1	3	7	10	6	4
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-3	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10	73	21
+ Other Non-Cash Adj	- -	- -	- -	- -	1	4	5	4	-2	4	3	49	35	57	31
+ Chg in Non-Cash Work Cap	- -	- -	1	- -	1	- -	7	-6	-1	15	1	-2	-20	-5	-1
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-19	-74	2	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -	- -	- -	- -	-1	-2	2	- -	-2	1	-4	2
+ Inc (Dec) in Accts Payable	- -	- -	1	- -	1	- -	7	-5	2	12	2	19	53	-3	-3
+ Inc (Dec) in Other	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-1	-2	-2	-4	-3	-7	-12	-25	-27	-30	-50	-69	-118	-78	-25
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	7	- -	7	-1	2	5	15	13	99	- -	- -
+ Cash From Debt	- -	- -	- -	- -	7	1	7	- -	2	5	15	15	100	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	-1	- -	-1	- -	- -	- -	-2	-1	- -	- -
+ Cash (Repurchase) of Equity	2	1	1	3	- -	14	- -	38	19	25	38	13	1	41	26
+ Increase in Capital Stock	2	1	1	3	- -	14	- -	38	19	25	38	13	1	41	26
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	- -	2	- -	- -	- -	-2	1	-3	-3	- -	-1	54	38	7	4
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	1	3	1	4	7	12	8	33	19	29	53	80	137	48	30
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	- -	- -	-1	-1	- -	4	-4	9	-8	-1	2	11	20	-30	5
Capital Expenditures	- -	- -	- -	- -	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA	-2	-4	-4	-7	-8	-8	-19	-21	-27	-46	-55	-73	-93	-71	-40
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-26,741.73	- -
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow	-1	-2	-2	-4	-7	-7	-12	-25	-27	-30	-51	-69	-118	-78	-25
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	-1	-6	-2	-6	3	-7	-5	-26	-24	-25	-35	-57	-20	-79	-27
Free Cash Flow per Basic Share	-0.09	-0.11	-0.09	-0.18	-0.23	-0.16	-0.21	-0.26	-0.19	-0.17	-0.19	-0.16	-0.2	-0.11	-0.03
Price/Free Cash Flow	-6.64	-15.52	-31.79	-8.41	195.62	-3.88	-4.62	-3.62	-3.15	-2.75	-2.16	-17.33	-9.91	-2.96	-9.33
Cash Flow to Net Income	0.82	0.57	0.49	0.59	0.35	0.59	0.48	0.97	1.04	0.6	0.9	0.55	0.76	0.37	0.31

CytoDyn Inc.

CYDY US

0.13